|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.55 TWD | +1.28% |
|
-2.57% | -33.10% |
| 03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-06 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Tanvex BioPharma, Inc. announced the resignation of Dr. Yun Yen as CEO. Resume of the previous position holder: Tanvex Biopharma, Inc. Chairman/CEO. Effective date is December 29, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.10% | 220M | |
| +5.66% | 111B | |
| +11.23% | 105B | |
| -12.15% | 22.34B | |
| -2.77% | 21.93B | |
| -6.17% | 18.59B | |
| -36.52% | 18.12B | |
| -10.09% | 16.96B | |
| +3.33% | 13.7B | |
| +36.58% | 12.45B |
TANVEX BIOPHARMA, INC. 
